Betterlife Pharma Inc
(BETRF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 01/31
| 10-2020 | 07-2020 | 04-2020 | 01-2020 | 10-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,691 | -1,094 | 276 | -14,784 | -6,737 |
| Depreciation Amortization | 208 | 186 | 91 | 1,063 | 557 |
| Accounts receivable | -69 | -57 | -1 | -70 | N/A |
| Other Working Capital | -154 | 221 | -216 | 228 | -1,458 |
| Other Operating Activity | 3,298 | -737 | -1,076 | 7,616 | 2,757 |
| Operating Cash Flow | $-3,408 | $-1,481 | $-926 | $-5,948 | $-4,882 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8 | -8 | N/A | -410 | N/A |
| Net Acquisitions | 19 | 0 | N/A | -327 | N/A |
| Purchase Sale Intangibles | -66 | -65 | -63 | N/A | -327 |
| Other Investing Activity | -66 | -382 | -63 | -125 | -493 |
| Investing Cash Flow | $-55 | $-390 | $-63 | $-861 | $-493 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 605 | N/A | N/A | -2,453 | -2,473 |
| Debt Repayment | N/A | N/A | N/A | -207 | -189 |
| Common Stock Issued | 1,071 | 617 | N/A | 12,309 | 12,321 |
| Other Financing Activity | -319 | -223 | -136 | -422 | 0 |
| Financing Cash Flow | $1,357 | $394 | $-136 | $9,227 | $9,659 |
| Exchange Rate Effect | 16 | -2 | 2 | 2 | 4 |
| Beginning Cash Position | 2,482 | 2,399 | 2,386 | 57 | 57 |
| End Cash Position | 392 | 920 | 1,264 | 2,477 | 4,344 |
| Net Cash Flow | $-2,090 | $-1,479 | $-1,123 | $2,420 | $4,288 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,408 | -1,481 | -926 | -5,948 | -4,882 |
| Capital Expenditure | -8 | -8 | N/A | -410 | N/A |
| Free Cash Flow | -3,416 | -1,489 | -926 | -6,357 | -4,882 |